Copy to clipboard 
OSSIO expanded its soft tissue fixation portfolio with the launch of OSSIOfiber 2.5mm Suture Anchors, which can support several surgical procedures, including Brostrom repair for lateral ankle instability.
System aspects include:
- Smaller. OSSIOfiber 2.5mm Suture Anchors are designed for procedures like Brostrom repair, a standard surgery to fix lateral ankle instability.
- Stronger. These new fixation implants offer 55% greater pull-out strength over the market-leading 2.4mm bio-composite suture anchor.
- Smarter. As with the rest of the company’s expanding product portfolio, OSSIOfiber Suture Anchors feature a novel material engineered without metal to integrate into bone, leaving a more natural orthopedic landscape with minimal risk of adverse reactions.
The device’s physical design supports an array of standard surgical techniques for fixating suture or soft tissue with a procedural workflow and instrumentation set that are both familiar and efficient, including drill bits and a slotted drill guide for easy drilling and anchor insertion. In addition, its versatile configuration options—specifically, unloaded and pre-loaded devices—allow for technical flexibility and respect varying surgeon preferences.
“In launching our latest OSSIOfiber platform, we’ve brought to market the first small, fully bio-integrative suture anchor, which outperforms current options for lateral ankle instability and other repairs,” OSSIO CEO Brian Verrier explained. “With this anchor, surgeons can perform these procedures with less impact and better results for patients, while adding fixation strength. The device also rounds out our best-in-class line of implants for soft tissue fixation.”
Indications for use: OSSIOfiber® Suture Anchors (2.5–3.5mm range) are intended to be used for suture or tissue fixation in the foot, ankle, knee, hand, wrist, elbow and shoulder, in adults and children (2–12 years) and adolescents (12–21 years) in which growth plates have fused or in which growth plates will not be crossed by fixation.
OSSIOfiber implants represent an alternative to metal, absorbable and allograft fixation devices. Looking ahead, the company intends to continue developing additional applications for OSSIOfiber implants in all major segments of orthopedics. Through June 2025, more than 50,000 OSSIOfiber implants have been used in the U.S.
Source: OSSIO Inc.
OSSIO expanded its soft tissue fixation portfolio with the launch of OSSIOfiber 2.5mm Suture Anchors, which can support several surgical procedures, including Brostrom repair for lateral ankle instability.
System aspects include:
Smaller. OSSIOfiber 2.5mm Suture Anchors are designed for procedures like Brostrom repair, a standard surgery...
OSSIO expanded its soft tissue fixation portfolio with the launch of OSSIOfiber 2.5mm Suture Anchors, which can support several surgical procedures, including Brostrom repair for lateral ankle instability.
System aspects include:
- Smaller. OSSIOfiber 2.5mm Suture Anchors are designed for procedures like Brostrom repair, a standard surgery to fix lateral ankle instability.
- Stronger. These new fixation implants offer 55% greater pull-out strength over the market-leading 2.4mm bio-composite suture anchor.
- Smarter. As with the rest of the company’s expanding product portfolio, OSSIOfiber Suture Anchors feature a novel material engineered without metal to integrate into bone, leaving a more natural orthopedic landscape with minimal risk of adverse reactions.
The device’s physical design supports an array of standard surgical techniques for fixating suture or soft tissue with a procedural workflow and instrumentation set that are both familiar and efficient, including drill bits and a slotted drill guide for easy drilling and anchor insertion. In addition, its versatile configuration options—specifically, unloaded and pre-loaded devices—allow for technical flexibility and respect varying surgeon preferences.
“In launching our latest OSSIOfiber platform, we’ve brought to market the first small, fully bio-integrative suture anchor, which outperforms current options for lateral ankle instability and other repairs,” OSSIO CEO Brian Verrier explained. “With this anchor, surgeons can perform these procedures with less impact and better results for patients, while adding fixation strength. The device also rounds out our best-in-class line of implants for soft tissue fixation.”
Indications for use: OSSIOfiber® Suture Anchors (2.5–3.5mm range) are intended to be used for suture or tissue fixation in the foot, ankle, knee, hand, wrist, elbow and shoulder, in adults and children (2–12 years) and adolescents (12–21 years) in which growth plates have fused or in which growth plates will not be crossed by fixation.
OSSIOfiber implants represent an alternative to metal, absorbable and allograft fixation devices. Looking ahead, the company intends to continue developing additional applications for OSSIOfiber implants in all major segments of orthopedics. Through June 2025, more than 50,000 OSSIOfiber implants have been used in the U.S.
Source: OSSIO Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
